⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases

Official Title: Radium-223 Chloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases

Study ID: NCT01516762

Study Description

Brief Summary: This study is a prospective, interventional, open-label, multi-center early access program for the use of Ra-223 Cl2 in HRPC/CRPC patients diagnosed with symptomatic bone metastasis and to collect additional short and long term safety data on the product.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: MALE

Healthy Volunteers: No

Locations

, Birmingham, Alabama, United States

, Phoenix, Arizona, United States

, Scottsdale, Arizona, United States

, Greenbrae, California, United States

, La Jolla, California, United States

, San Francisco, California, United States

, Stanford, California, United States

, Aurora, Colorado, United States

, Newark, Delaware, United States

, Washington, District of Columbia, United States

, Washington, District of Columbia, United States

, Fort Myers, Florida, United States

, Miami Beach, Florida, United States

, Tampa, Florida, United States

, Atlanta, Georgia, United States

, Honolulu, Hawaii, United States

, Goshen, Indiana, United States

, Iowa City, Iowa, United States

, New Orleans, Louisiana, United States

, Shreveport, Louisiana, United States

, Baltimore, Maryland, United States

, Baltimore, Maryland, United States

, Baltimore, Maryland, United States

, Bethesda, Maryland, United States

, Rockville, Maryland, United States

, Boston, Massachusetts, United States

, Boston, Massachusetts, United States

, Ann Arbor, Michigan, United States

, Detroit, Michigan, United States

, Detroit, Michigan, United States

, Minneapolis, Minnesota, United States

, St. Louis, Missouri, United States

, Las Vegas, Nevada, United States

, New Brunswick, New Jersey, United States

, Newark, New Jersey, United States

, New Hyde Park, New York, United States

, New York, New York, United States

, New York, New York, United States

, Syracuse, New York, United States

, Durham, North Carolina, United States

, Raleigh, North Carolina, United States

, Cleveland, Ohio, United States

, Columbus, Ohio, United States

, Springfield, Oregon, United States

, Philadelphia, Pennsylvania, United States

, Philadelphia, Pennsylvania, United States

, Philadelphia, Pennsylvania, United States

, Pittsburgh, Pennsylvania, United States

, Myrtle Beach, South Carolina, United States

, Myrtle Beach, South Carolina, United States

, Nashville, Tennessee, United States

, Houston, Texas, United States

, Plano, Texas, United States

, San Antonio, Texas, United States

, Temple, Texas, United States

, Hampton, Virginia, United States

, Norfolk, Virginia, United States

, Seattle, Washington, United States

, Wheeling, West Virginia, United States

, Milwaukee, Wisconsin, United States

Contact Details

Name: Bayer Study Director

Affiliation: Bayer

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: